- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04012372
ROSA Oligomineral Water for Oral Hydration in 6-Month-Old Healthy Infants (ROSAH)
October 15, 2019 updated by: University of Novi Sad, Faculty of Sport and Physical Education
Short-term Safety of ROSA Oligomineral Water in Healthy Serbian Infants
The present study evaluates the safety of ROSA oligomineral water in 6-to-12-month old healthy children.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Our study is designed as an open-label case-control interventional study that evaluates the safety of 28-day hydration with ROSA water in healthy infants aged 6-12 months.
The participants are apparently healthy children breastfed or formula fed; minimal sample size (n = 52) was calculated according to 0.8 power to detect a significant difference in the prevalence of diarrhea (G*Power 3.1).
Final group of participants will consist of sixty-five healthy male and female infants (we presume that 20% of participants will drop-out throughout the study).
The stopping rules for participants include a refuse to participate in this research at any time and significant change of health status.
All participants will be allocated in an open-label manner to two randomly assigned ad libitum hydration regimens: first group will receive ROSA water for daily hydration, and second (control) group will receive other water of personal choice (including tap water).
All testing including parental diary of infant general status (e.g.
daily amount of water consumed, number of stools per day, nutritional habits) and clinician-reported outcomes (e.g.
body weight, clinical evaluation of hydration will be conducted at pre-administration (baseline) and at follow-up (after 28 days of administration).
The study is entirely voluntary and the participants are free to stop participating at any time.
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Niš, Serbia
- Dom zdravlja Nis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 1 year (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 6 to 12 months
- Healthy children
- Doubled weight at 6 months
- Tripled weight at 12 months
- Feed with breast milk of milk formula
Exclusion Criteria:
- Any acute or chronic disease
- Unwillingness to return for follow-up analysis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: ROSA water
Ad libitum hydration with ROSA oligomineral water
|
Ad libitum hydration with ROSA oligomineral water
|
ACTIVE_COMPARATOR: Control water
Ad libitum hydration with other waters
|
Ad libitum hydration with other waters
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Daily amount of water consumed
Time Frame: Baseline vs. 28-days
|
Monitor change in daily amount of water consumed
|
Baseline vs. 28-days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of stools per day
Time Frame: Baseline vs. 28-days
|
Monitor change in number of stools per day
|
Baseline vs. 28-days
|
Body weight
Time Frame: Baseline vs. 28-days
|
Monitor change in body weight
|
Baseline vs. 28-days
|
Hydration status
Time Frame: Baseline vs. 28-days
|
Monitor clinican-reported change in hydration status
|
Baseline vs. 28-days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Milorad Jerkan, MD, PhD, Dom zdravlja Nis
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 20, 2019
Primary Completion (ACTUAL)
August 31, 2019
Study Completion (ACTUAL)
October 7, 2019
Study Registration Dates
First Submitted
July 4, 2019
First Submitted That Met QC Criteria
July 4, 2019
First Posted (ACTUAL)
July 9, 2019
Study Record Updates
Last Update Posted (ACTUAL)
October 16, 2019
Last Update Submitted That Met QC Criteria
October 15, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hydration
-
Liquid I.V.Lipscomb UniversityCompletedFluid Retention | Beverage Hydration Index | Hydration StatusUnited States
-
Abbott NutritionRecruiting
-
University of MemphisNuun & CompanyCompletedHydrationUnited States
-
University of MemphisNuun & CompanyCompleted
-
University of MemphisRecruiting
-
University Hospitals, LeicesterRecruitingHydrationUnited Kingdom
-
University of MemphisNuun & Company, Inc (Nuun)CompletedHydrationUnited States
-
PepsiCo Global R&DRecruiting
-
IRCCS Policlinico S. DonatoCompleted
Clinical Trials on ROSA Water
-
Lawson Health Research InstituteZimmer BiometRecruiting
-
Zimmer BiometCompleted
-
Mahidol UniversityCompleted
-
University Hospital, MontpellierMedtech S.A.SCompleted
-
Stony Brook UniversitySuspendedBack Pain | Sciatica | Back Pain, LowUnited States
-
Zimmer BiometUniversity of Pittsburgh Medical CenterWithdrawnIntracerebral HematomaUnited States
-
Centre Hospitalier Universitaire de BesanconCompletedPalliative Care | Hematological Malignancy | Platelet TransfusionFrance
-
A.O. Ospedale Papa Giovanni XXIIIMedtronic; Case Western Reserve UniversityCompletedAcute Myocardial InfarctionItaly
-
Georgetown UniversityNational Cancer Institute (NCI); Virginia Commonwealth UniversityEnrolling by invitation
-
University of California, Los AngelesRecruitingKnee OsteoarthritisUnited States